Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Helen Vlassara, Richard Bucala, Liliane J. Striker · PubMed · 1994 · 853 citations

Life Sciences, Biochemistry, Endocrinology +16

Impaired Nitric Oxide Synthase Pathway in Diabetes Mellitus

Ken Y. Lin, Akira Ito, Tomoko Asagami et al. · Circulation · 2002 · 658 citations

Medicine, Endocrinology, Pharmacology +14

Improvement of Nitric Oxide–Dependent Vasodilatation by HMG-CoA Reductase Inhibitors Through Attenuation of Endothelial Superoxide Anion Formation

Andreas H. Wagner, Thomas Köhler, Uwe Rückschloss et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2000 · 518 citations

Life Sciences, Biochemistry, Pharmacology +17

Effect of Intensive Lipid Lowering with Atorvastatin on Renal Function in Patients with Coronary Heart Disease

James Shepherd, John J.P. Kastelein, Vera Bittner et al. · Clinical Journal of the American Society of Nephrology · 2007 · 271 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression

Sho‐ichi Yamagishi, Kazuo Nakamura, Takanori Matsui et al. · Journal of Biological Chemistry · 2006 · 218 citations · Full text

Medicine, Ophthalmology, Pharmacology +17